Logo

Guardant Health

GenomeWeb Index up Slightly in August as Guardant Health Leads on Strength of Q2 Earnings

The GenomeWeb Index outperformed the Dow Jones last month, but underperformed the Nasdaq and the Nasdaq Biotechnology Index.

People in the News: New Appointments at Guardant Health, Foundation Medicine, PGDx, GenapSys, More

Guardant Health Laying Path for Future in Cancer Screening, Updates Launch Plans for CRC Assay
Premium

The firm said it will release its colorectal cancer test as an LDT next year and has reorganized its leadership to support future growth in the cancer screening market.

Guardant Health Q2 Revenues Grow 39 Percent

The firm's oncology testing revenues outpaced other revenue sources, driven by a more than 50 percent increase in clinical test volume.

TwinStrand Biosciences Sues Guardant Health for Alleged Patent Infringement

The company argued in its complaint that Guardant's liquid biopsy assays have willfully infringed its patented duplex sequencing technology.

Jul 19, 2021

Korean AI Pathology Startup Lunit Nabs $26M Investment from Guardant Health; Plans Collaboration

Jun 22, 2021

Guardant Health Targets Emerging Treatment Response Market With New ctDNA Product
Premium

Jun 1, 2021

GenomeWeb Index Down in May as NanoString Technologies Falls 30 Percent From April

May 28, 2021

FDA Approves Amgen's Lumakras for NSCLC Alongside Companion Tests From Guardant Health, Qiagen

May 28, 2021

Guardant Health Sues Natera for False Advertising, 'Misleading' Oncologists About MRD Tests

May 21, 2021

Guardant Health to License IP to Foundation Medicine for $25M, Royalties Under Settlement Agreement

May 21, 2021

FDA Approves Janssen's Rybrevant, Guardant360 CDx for EGFR Exon 20-Mutated NSCLC

May 7, 2021

Guardant MRD Test Performs Well in Small Study as Tissue-Informed Debate Takes Shape
Premium

May 6, 2021

Guardant Health Q1 Revenues up 17 Percent

Apr 14, 2021

Guardant AACR Data Highlights Value of Clinical Test Database to Drive Drug Resistance Discoveries

Apr 1, 2021

Guardant Health Receives New York State Approval for Guardant Reveal MRD Test

Mar 2, 2021

Guardant360 CDx Receives CE Mark for Tumor Mutational Profiling and Tagrisso CDx Use

Feb 26, 2021

Guardant Health Begins First Foray Into Early-Stage Cancer With Commercial MRD Test Launch
Premium

Feb 24, 2021

Guardant Health Q4 Revenues Up 25 Percent

Feb 19, 2021

New Products Posted to GenomeWeb: Guardant Health, Parse Biosciences, Menarini Silicon Biosystems

Feb 5, 2021

Guardant Health Turns to Tumor Tissue Sequencing to Broaden Offering
Premium

Jan 12, 2021

JP Morgan Healthcare Conference 2021, Day 2: Roche, Seer, 10x, Guardant, Hologic, Thermo Fisher

Dec 18, 2020

People in the News: New Appointments at Fluidigm, Danaher, Guardant Health

Dec 9, 2020

Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project

Nov 17, 2020

Guardant Health Prices $1B Senior Notes Offering

Breaking News
The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.